SUMMARY We describe 3 infants with nephrocalcinosis and terminal renal failure. In all 3 there was widespread oxalate deposition: biochemical evidence of primary hyperoxaluria was sought but the presence of severe renal failure and the lack of established normal values for urinary and plasma oxalate and glycollate in infants made this diagnosis difficult to establish.
Oxalosis is the widespread deposition of calcium oxalate crystals throughout the body.' In primary oxalosis a recessively inherited enzyme defect in organic acid metabolism causes oxalate accumulation; at least two types have been described in children and young adults but there have been few reports of the condition in infancy. [2] [3] [4] [5] [6] [7] The clinical consequences of primary oxalosis are mainly renal with nephrocalcinosis, stone formation, and progressive renal insufficiency. Secondary oxalosis occasionally results from excessive intake of oxalate or its precursors (for example ethylene glycol antifreeze), but more commonly it results from decreased oxalate excretion in chronic renal failure from any cause. We describe the investigations and clinical course of 3 infants with oxalosis and discuss the difficulties in establishing whether it was primary or secondary.
Case reports Case 1. An 11-month-old boy was admitted to Guy's Hospital with a short history of pallor and breathlessness; unusual thirst had been noted from age 1 month. He had been born in Kuwait of healthy unrelated Jordanian parents, and had 4 healthy siblings. His birthweight had been 3-75 kg. On admission his weight was 7.36 kg and blood pressure 160 mmHg systolic. There was no peripheral oedema. A 'pepper and salt' retinopathy was noted. Details of plasma biochemistry are shown in Tables 1  and 2 . Abdominal x-ray film showed bilateral nephrocalcinosis; an intravenous urogram (IVU) showed no excretion of contrast, and a voiding cystogram was normal. A (Cases 2 and 3) , or by biopsy and x-ray evidence (Case 1). In Case 1 the need for open renal biopsy was avoided by finding calcium oxalate crystals in the bone marrow cavity. The presence of these crystals in the bone marrow has long been recognised in patients with oxalosis, and Dunn'2 suggested bone marrow aspiration as a simple diagnostic test. However, in Case 1 the crystals could not be found in 2 bone marrow aspirate samples, but could easily be seen in the trephine biopsy specimen so we believe that trephine biopsy is the preferable diagnostic procedure in these patients. Evidence of primary hyperoxaluria was established in Case 1 in whom oxalate excretion, corrected for surface area, was slightly raised, the oxalate to creatinine ratio increased as was the urinary glycollate level. The plasma oxalate was greatly increased, but the simultaneous plasma creatinine was 540 ,tmol/l (6-1 mg/100 ml). Plasma oxalate levels can rise as high as 80 Vmol/l (757 mg/100 ml) in adults with advanced chronic renal failure from causes other than primary hyperoxaluria. Plasma oxalate is slightly raised in adults with primary hyperoxaluria and normal plasma creatinine levels, and rises disproportionately rapidly when renal failure intervenes.13 As the level of plasma creatinine is much lower in normal infants than in normal adults, and we have no information on normal plasma oxalate levels in infancy, we did not know if the plasma oxalate was disproportionately high in Case 1. In Case 2, the biochemical diagnosis of hyperoxaluria was not established. The urinary oxalate excretion was normal. However, her urinary volume was greatly diminished, and the diagnosis of hyperoxaluria is complicated by the presence of renal failure, as urinary oxalate excretion may decrease and even fall within the normal range as renal failure becomes more advanced. In Case 3, urinary studies could not be undertaken as the patient was anuric. The plasma oxalate, measured by gas chromatography, was 33 ,umol/l (326 mg/100 ml) with a simultaneous plasma creatinine of 750 Cumol/l (8-48 mg/100 ml). The normal range for plasma oxalate using this method had not been established, but the elder brother of Case 3, who had no clinical or biochemical evidence of primary hyperoxaluria had a plasma oxalate level of 5-6 ,umol/l (53 mg/ 100 ml). Thus although the plasma oxalate in Case 3 was high it did not seem disproportionately so compared with his plasma creatinine level. Plasma glycerate measured by gas chromatography was 6.6 ,mol/l (0-62 mg/100 ml) in the patient and 22 ,umol/l (2.1 mg/100 ml) in his brother and plasma glycollate 26 ,umol/l (2 mg/100 ml) compared with 68 Vmol/l (5-2 mg/100 ml): normal ranges by this method have not been established in children.
We are confident that these children had primary oxalosis. We 
